Le pluralisme politique à l’épreuve de la vie privée : entre normes et pratiques

L’espace des relations interpersonnelles et privées, en tant qu’espace de politisation et d’expression des choix politiques, est peu connu. C’est à une meilleure connaissance du « citoyen privé » et de la « politisation intime » que cet article veut contribuer, en étudiant les ressemblances et les divergences idéologiques au sein du cercle des proches. Présentant les résultats d’une enquête quantitative et représentative de la population française inédite, « Famille, amour et politique », réalisée par le CEVIPOF, il examine la filiation, la conjugalité, et l’amitié et montre les interactions et les transactions qui opèrent entre le système des normes et le système des affects des individus. La famille apparaît plus hétérogame politiquement tandis que le couple et le cercle des amis sont plus homogames. Toutefois, c’est le niveau de politisation des individus qui est en dernière instance le plus déterminant. Une affiliation politique affirmée, et tout particulièrement à gauche, ainsi qu’un intérêt marqué pour la politique, renforcent toujours l’homogamie politique au sein du cercle des proches, dans les principes comme dans les faits. Plus largement, l’article ouvre une réflexion sur l’espace de la vie privée en tant que terrain d’expérience des conditions de la pluralité démocratique.Little is known of the role played by private interpersonal relationships in politicization and the expression of political choices. This article aims to improve our understanding of “private citizens” and “personal politicization” through a study of ideological similarities and divergences within family and friendship circles. The analysis, based on findings from an unprecedented quantitative representative French population survey by the CEVIPOF (Center for the study of French political life) entitled “Famille, amour et politique” [Family, love and politics], examines filiation, conjugality and friendship, showing the interactions and transactions that take place between the system of norms and the system of individual feelings. Families appear more heterogamous politically, while couples and friendship circles are more homogamous. However, individuals’ level of politicization is ultimately the most determinant factor. Having a strong political affiliation, particularly on the left of the political spectrum, and a strong interest in politics always strengthens intra-circle political homogamy in terms of both principles and actions. At a more general level, the article reflects on the sphere of private life as a field for the development of conditions of democratic pluralism

ИНДИВИДУАЛЬНЫЙ ПОДХОД К ПРИМЕНЕНИЮ АНТИТРОМБОЦИТАРНОЙ ТЕРАПИИ. НА ЧТО ОПЕРЕТЬСЯ В РЕШЕНИИ?

Use of antiplatelet therapy in the world indicates real difference in individual drug effect between patients, including the effect on prognosis. Problems of personification of individual approach, concerning antiplatelet therapy, are discussed.Опыт применения антиагрегантной терапии указывает на существенную разницу в реакции больных на антиагреганты, вызывающую различия в выраженности эффекта терапии по влиянию на исходы заболевания. Обсуждены проблемы индивидуального подхода в антиагрегантной терапии

NEW ANTIPLATELET DRUGS (PART 1)

Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties of antiplatelet treatment lie in the balance between the necessary therapeutic effect of the drug and the risk of excessive action leading to the bleeding. Possibility to control pharmacodynamics effects of antiplatelet agents is still very limited. Pharmacology of antiplatelet drugs is growing rapidly. Some of new antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, inhibitors of thromboxane and thrombin receptors. Clinical pharmacology of these drugs is different. This requires a doctor's good knowledge of their identity to avoid the development of iatrogenic complications.</p

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?

Commentary on the paper “Age and effectiveness and safety of various antithrombotic therapy variants in patients with nonvalvular atrial fibrillation” by Shevelev V. I. and Kanorskyi S. G. (Cardiovascular Therapy and Prevention 2013;12 (1):46–53)

NEW ANTIPLATELET DRUGS (PART 1)

Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties of antiplatelet treatment lie in the balance between the necessary therapeutic effect of the drug and the risk of excessive action leading to the bleeding. Possibility to control pharmacodynamics effects of antiplatelet agents is still very limited. Pharmacology of antiplatelet drugs is growing rapidly. Some of new antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, inhibitors of thromboxane and thrombin receptors. Clinical pharmacology of these drugs is different. This requires a doctor's good knowledge of their identity to avoid the development of iatrogenic complications